ImmunoGen, Inc. - Strategy, SWOT and Corporate Finance Report
SummaryImmunoGen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
ImmunoGen, Inc. (ImmunoGen or ‘the company’) is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology is comprised of the company's portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. The major partners of the company include Roche, Huadong, CytomX, Debiopharm, Bayer, Novartis, Oxford BioTherapeutics/Menarini, Fusion and Viridian use the company's ADC technology to develop anticancer therapies. ImmunoGen is headquartered in Waltham, Massachusetts, the US.
Scope
- Detailed information on ImmunoGen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting ImmunoGen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of ImmunoGen, Inc. including a breakdown and examination of key business segments
- Intelligence on ImmunoGen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about ImmunoGen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of ImmunoGen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess ImmunoGen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on ImmunoGen, Inc.'s business structure, strategy and prospects.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.